Medical Alerts

Mar 26, 2020
COVID-19 Neurology Resources
Stay up-to-date with the latest information and resources for clinicians during the COVID-19 crisis.
Mar 04, 2020
FDA takes rare step to ban electrical stimulation devices for self-injurious or aggressive behavior
Devices found to present unreasonable and substantial risk of illness or injury.
Dec 19, 2019
Nerve drugs gabapentin, pregabalin linked to breathing problems
The agency will add new warning labels to the drugs.
Nov 22, 2019
FDA approves new treatment for adults with partial-onset seizures
XCOPRI (cenobamate tablets) is a new option to treat adults with partial-onset seizures.
Oct 30, 2019
FDA approves diroximel fumarate for relapsing forms of multiple sclerosis
Drug is a novel oral fumarate with a distinct chemical structure that is designed to impact its gastrointestinal tolerability.
Oct 24, 2019
FDA Approves Botox for Lower-Limb Spasticity in Children
Approval marks onabotulinumtoxinA’s 11th therapeutic indication.
Oct 11, 2019
FDA approves new treatment for patients with migraine
New drug approved for treatment of migraine with or without aura in adults.
Aug 28, 2019
FDA approves new add-on drug to treat off episodes in adults with Parkinson disease
Patients treated with drug experienced statistically significant decrease from baseline in daily “off” time.
Aug 15, 2019
FDA approves first non-controlled substance treatment for narcolepsy
Medication represents the first and only non-scheduled treatment approved for patients with narcolepsy in the United States.
Jul 10, 2019
CDC urges doctors to rapidly recognize and report acute flaccid myelitis cases
Intense effort underway to understand and prevent this serious neurologic syndrome.
Next ▶